RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Cases of prostate cancer are on the rise in California, according to new research. A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study by UC San Francisco.

The Walnut Foundation is on a mission to raise the profile of prostate cancer awareness and knowledge in Black communities across Canada. Stay tuned! The remaining three recipients are in the ...

While prostate cancer is becoming more prevalent among middle-aged and elderly men in China, clinical practice still faces considerable challenges due to the lack of unified guidelines and high ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...